TrialThe Lancet. Neurology2015

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.

Ronit M Pressler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.